N. Friedmann

869 total citations
27 papers, 639 citations indexed

About

N. Friedmann is a scholar working on Anesthesiology and Pain Medicine, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, N. Friedmann has authored 27 papers receiving a total of 639 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Anesthesiology and Pain Medicine, 9 papers in Pharmacology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in N. Friedmann's work include Pain Management and Opioid Use (9 papers), Opioid Use Disorder Treatment (4 papers) and Pharmacology and Obesity Treatment (3 papers). N. Friedmann is often cited by papers focused on Pain Management and Opioid Use (9 papers), Opioid Use Disorder Treatment (4 papers) and Pharmacology and Obesity Treatment (3 papers). N. Friedmann collaborates with scholars based in United States, United Kingdom and Russia. N. Friedmann's co-authors include Lindsay H. Burns, Lynn R. Webster, P. Butera, Nancy Wu, Lauren V. Moran, Richard Craven, Vishala Chindalore, Betty J Nelson, Nancy Wedel and Robert J. Bauer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

N. Friedmann

27 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Friedmann United States 13 184 180 163 142 129 27 639
Nabil Al‐Tawil Sweden 11 46 0.3× 83 0.5× 61 0.4× 33 0.2× 33 0.3× 22 407
Anders Ölund Sweden 13 25 0.1× 96 0.5× 134 0.8× 38 0.3× 20 0.2× 38 557
Howard Schwartz United States 17 49 0.3× 84 0.5× 22 0.1× 25 0.2× 356 2.8× 27 1.3k
Klaus P. Kohse Germany 17 35 0.2× 261 1.4× 77 0.5× 8 0.1× 15 0.1× 40 797
T. E. Emerson United States 11 185 1.0× 55 0.3× 77 0.5× 5 0.0× 34 0.3× 29 544
William P. Boger United States 20 31 0.2× 88 0.5× 152 0.9× 8 0.1× 87 0.7× 67 1.1k
Takao Takizawa Japan 18 56 0.3× 526 2.9× 33 0.2× 6 0.0× 51 0.4× 71 1.3k
Linda Gelgor Australia 15 140 0.8× 204 1.1× 30 0.2× 62 0.4× 66 0.5× 22 709
P.W. Ind United Kingdom 16 189 1.0× 1.3k 7.5× 22 0.1× 18 0.1× 41 0.3× 33 1.8k
Peter Reid United Kingdom 11 430 2.3× 91 0.5× 42 0.3× 4 0.0× 71 0.6× 16 890

Countries citing papers authored by N. Friedmann

Since Specialization
Citations

This map shows the geographic impact of N. Friedmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Friedmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Friedmann more than expected).

Fields of papers citing papers by N. Friedmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Friedmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Friedmann. The network helps show where N. Friedmann may publish in the future.

Co-authorship network of co-authors of N. Friedmann

This figure shows the co-authorship network connecting the top 25 collaborators of N. Friedmann. A scholar is included among the top collaborators of N. Friedmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Friedmann. N. Friedmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hoau-Yan, et al.. (2023). Simufilam suppresses overactive mTOR and restores its sensitivity to insulin in Alzheimer’s disease patient lymphocytes. SHILAP Revista de lepidopterología. 4. 1175601–1175601. 7 indexed citations
2.
Wang, H.-Y., et al.. (2020). PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients. The Journal of Prevention of Alzheimer s Disease. 7(4). 256–264. 36 indexed citations
3.
Friedmann, N., et al.. (2018). A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation. Journal of Opioid Management. 14(6). 437–443. 2 indexed citations
4.
Kucera, Shawn A., et al.. (2018). Abuse-deterrent properties of REMOXY® ER, a high-viscosity extended-release oxycodone formulation. Journal of Opioid Management. 14(6). 429–436. 1 indexed citations
5.
6.
Friedmann, N., et al.. (2011). Efficacy and safety of an extended-release oxycodone (Remoxy®) formulation in patients with moderate to severe osteoarthritic pain. Journal of Opioid Management. 7(3). 193–202. 27 indexed citations
7.
8.
Webster, Lynn R., P. Butera, Lauren V. Moran, et al.. (2006). Oxytrex Minimizes Physical Dependence While Providing Effective Analgesia: A Randomized Controlled Trial in Low Back Pain. Journal of Pain. 7(12). 937–946. 99 indexed citations
9.
Chindalore, Vishala, et al.. (2005). Adding Ultralow-Dose Naltrexone to Oxycodone Enhances and Prolongs Analgesia: A Randomized, Controlled Trial of Oxytrex. Journal of Pain. 6(6). 392–399. 85 indexed citations
10.
11.
Martin, PJ, FR Appelbaum, Claudio Anasetti, et al.. (1996). Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation. Blood. 88(3). 824–830. 4 indexed citations
12.
Kimmings, A N, Nancy Wedel, Marcel L.C.M. Mevissen, et al.. (1995). Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing Protein. The Journal of Infectious Diseases. 172(1). 144–151. 98 indexed citations
13.
Winter, Rob J. de, Nancy Wedel, Betty J Nelson, et al.. (1995). Recombinant endotoxin-binding protein (rBPI23) attenuates endotoxin-induced circulatory changes in humans.. PubMed. 45(3). 193–206. 18 indexed citations
14.
Mehlisch, Donald R., et al.. (1984). A double-blind evaluation of suprofen, aspirin and an oxycodone combination analgesic in post-operative pain. Pain. 18. S237–S237. 1 indexed citations
15.
Gordon, Steven A., et al.. (1984). A double-blind evaluation of two dosage regimens of suprofen and ibuprofen in primary dysmenorrhea. Pain. 18. S238–S238. 1 indexed citations
16.
Friedmann, N.. (1981). Effect on Growth in Pemoline-Treated Children With Attention Deficit Disorder. Archives of Pediatrics and Adolescent Medicine. 135(4). 329–329. 9 indexed citations
17.
Chun, Alexander, et al.. (1980). Bioavailability of Valproic Acid Under Fasting/ Nonfasting Regimens. The Journal of Clinical Pharmacology. 20(1). 30–36. 32 indexed citations
18.
Sennello, Lawrence T., et al.. (1979). Simultaneous Analysis of the Single and Multiple Dose Pharmacokinetics of the Non-Steroidal Anti-Inflammatory, Alclofenac. Journal of International Medical Research. 7(4). 253–262. 1 indexed citations
19.
Hardy, Mark A., et al.. (1976). The effect of thymosin on human T-cells from cancer patients. Cancer. 37(1). 98–103. 24 indexed citations
20.
Ma, Hardy, et al.. (1976). In vitro effect of thymosin on T cells from immunodepressed surgical patients.. PubMed. 80(2). 238–45. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nabil Al‐Tawil Breakdown of academic impact, for papers by Anders Ölund Breakdown of academic impact, for papers by Howard Schwartz Breakdown of academic impact, for papers by Klaus P. Kohse Breakdown of academic impact, for papers by T. E. Emerson Breakdown of academic impact, for papers by William P. Boger Breakdown of academic impact, for papers by Takao Takizawa Breakdown of academic impact, for papers by Linda Gelgor Breakdown of academic impact, for papers by P.W. Ind Breakdown of academic impact, for papers by Peter Reid
Rankless by CCL
2026